New Guidelines Aim to Improve Breast Cancer Detection in Women with Dense Breasts
National guidelines released this week will require doctors to inform patients with dense breasts about potential screening limitations and additional risk factors, a change prompted by cases like that of Krysty Sullivan, who was diagnosed with aggressive breast cancer just eleven months after a clear mammogram.
A routine mammogram in 2019 initially gave Krysty Sullivan peace of mind. However, less than a year later, she discovered a lump, leading to a diagnosis of triple-negative breast cancer – an aggressive form of the disease that doesn’t respond to common targeted treatments. Sullivan, then 48 years old, underwent a double mastectomy and 16 rounds of chemotherapy. The experience left her questioning what she might have missed, particularly as she was never informed about her high breast density.
The core issue, as highlighted by Sullivan’s case, is the reduced effectiveness of mammograms in women with dense breasts. Breast density, categorized using the Bi-rads system, refers to the proportion of fibrous and glandular tissue versus fatty tissue. Women with Bi-rads C or D classifications – indicating high density – have less fatty tissue, making it harder to detect subtle abnormalities like early-stage cancers. Sullivan was classified as Bi-rads D, the highest density category, but was not informed of this after her initial screening.
Did you know? – Mammograms are less effective at detecting cancer in women with dense breasts as dense tissue appears white on a mammogram, similar to cancerous tumors.
New national guidelines, released by the federal health department on Thursday, address this critical gap in patient care. The guidelines mandate that GPs inform patients if a mammogram reveals high breast density and provide additional guidance on appropriate next steps.For individuals with Bi-rads D density, the guidelines specifically recommend consideration of additional imaging techniques.
The updated guidance also emphasizes a personalized risk assessment. GPs are advised to inquire about family history and other risk factors to determine a woman’s overall breast cancer risk. Depending on this assessment, women with high breast density might potentially be offered additional screening options covered by Medicare.
Dr.Anna Withanage dona, a research fellow at the University of Melbourne involved in developing the guidance, explained the previous inconsistency in advice given to GPs. “These guidelines will give doctors better tools and help them explain what breast density means for each individual person, and when to consider further tests or a formal risk assessment,” she said. Importantly, the guidelines aim to avoid unnecessary anxiety or over-screening, clarifying that high breast density does not automatically equate to a cancer diagnosis.
Pro tip: – Don’t hesitate to ask your doctor about your breast density after a mammogram. Understanding your risk is the first step toward proactive health management.
The goal is to identify those women who would benefit most from supplemental screening, particularly those with additional risk factors. Dr. Katrina Tiller, chair of breast medicine at the Royal australian College of General Practitioners, noted that while BreastScreen has been reporting breast density for some time, consistent guidance for GPs has been lacking. “This is a nuanced area, and GPs need support to provide their patients with evidence-based advice,” she stated. “The guidance is both needed and welcome.The focus for now is getting this information out to GPs and raising awareness.”
Sullivan, who served as a consumer representative for the Breast Cancer network Australia during the guideline development, hopes the changes will empower women to advocate for their health.
Reader question: – What additional imaging techniques might be recommended for women with dense breasts and increased risk? Share your thoughts.
Why: The new national guidelines were created to address the reduced effectiveness of mammograms in women with dense breasts and to ensure patients are informed about potential screening limitations and additional risk factors. Krysty Sullivan’s
